Table 1 Summary of treatment targets of hypertension in major guidelines
From: Advancing evidence-based blood pressure targets in JSH2025
Guidelines | Target BP |
|---|---|
JSH2025 | • General treatment target: office BP < 130/80 mmHg; home BP < 125/75 mmHg |
• No separate BP targets by age or comorbidity; apply clinical judgment to avoid adverse events | |
• Individualized BP treatment targets when clinically appropriate | |
2025 AHA/ACC | • General treatment target: office/home BP < 130/80 mmHg, with encouragement to achieve SBP < 120 mmHg when feasible |
• No separate BP targets by age, comorbidity, or frailty; apply clinical judgment to avoid adverse events | |
2024 ESC | • General treatment target: office/home BP 120–129/70–79 mmHg |
• Age ≥85 years with moderate to severe frailty, orthostatic hypotension, or limited life expectancy (<3 years): SBP < 140 mmHg or ALARA | |
2023 ESH | • General treatment target: office BP < 140/80 mmHg |
• Age-related treatment targets: | |
- 18–64 years: 120–129/70–79 mmHg | |
- 65–79 years: <140/80 mmHg, but 120–129/70–79 mmHg may be considered if well tolerated | |
- ≥80 years: SBP of 140–150, but SBP of 130–139 mmHg may be considered if well tolerated | |
• Frailty: individualized treatment target |
